BioSpace News Archive

The global pulmonary drug delivery systems market was estimated at USD 51.87 billion in 2021, and it is expected to be worth around USD 92.4 billion by 2030 with a CAGR of 6.6% in next 10 years.

The global in-vitro fertilization market is expected to grow at 8.6% from 2021 to 2030 and it is projected to surpass around USD 33 Billion by 2030.

BioChain Institute, a leader in high-quality processed bio-sample products is excited to adopt GeoMx platform to provide digital spatial profiling services.

Jasper Therapeutics, Inc., (NASDAQ: JSPR) today announced updated efficacy, safety and pharmacokinetic data from its ongoing multicenter Phase 1 clinical trial of JSP191, the company’s first-in-class anti-CD117 monoclonal antibody, as a targeted, non-toxic conditioning regimen in older patients with myelodysplastic syndromes (MDS) or acute myeloid leukemia (AML) undergoing allogeneic hematopoietic (blood) cell transplantation.

Exact Sciences Corp., a leader in advanced cancer diagnostics, announced that the company generated revenue of $486.6 million for the first quarter ended March 31, 2022, compared to $402.1 million for the same period of 2021.

Outset Medical, Inc. announced that members of management will present at the BofA Securities 2022 Healthcare Conference on Tuesday, May 10, 2022 at 12:00pm PT / 3:00pm ET.

Exelixis, Inc. (Nasdaq: EXEL) announced today that its first quarter 2022 financial results will be released on Tuesday, May 10, 2022 after the markets close.

ProQR Therapeutics N.V. (Nasdaq: PRQR) (the “Company”), a company dedicated to changing lives through the creation of transformative RNA therapies, today announced several presentations at the 7th Annual Retinal Cell and Gene Therapy Innovation Summit being held Friday, April 29, 2022 and the Annual Meeting.

Silk Road Medical, Inc., a company focused on reducing the risk of stroke and its devastating impact, announced the company will participate in the upcoming BofA Securities 2022 Healthcare Conference.

Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, will release first quarter 2022 financial results on Tuesday, May 10, 2022, prior to the market open.